Kura Oncology (KURA) Non Operating Income (2014 - 2026)

Kura Oncology (KURA) has 13 years of Non Operating Income data on file, last reported at $5.5 million in Q1 2026.

• On a quarterly basis, Non Operating Income fell 26.77% year-over-year to $5.5 million in Q1 2026; TTM through Mar 2026 was $23.7 million, a 0.32% change from a year earlier, with the FY2025 full-year figure at $25.3 million, up 18.99% from the prior year.
• Non Operating Income for Q1 2026 stood at $5.5 million, down from $7.5 million in the prior quarter.
• Over the last five years, Non Operating Income for KURA reached as high as $7.5 million in Q1 2025 and fell as low as $329000.0 in Q1 2022.
• Historically, Non Operating Income has averaged $3.7 million across 5 years, with a median of $3.9 million in 2023.
• Across the five-year window, Non Operating Income surged 3625.0% in 2022 and fell 26.77% in 2026, its largest moves.
• Year by year, Non Operating Income stood at $2.0 million in 2022, then jumped by 94.71% to $4.0 million in 2023, then jumped by 32.19% to $5.3 million in 2024, then soared by 42.64% to $7.5 million in 2025, then decreased by 26.77% to $5.5 million in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were $5.5 million in Q1 2026, $7.5 million in Q1 2025, and $5.3 million in Q4 2024.